AstraZeneca

AstraZeneca

Verified
A global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-22.5b22.1b24.4b26.6b37.4b44.0b
% growth--(2 %)10 %9 %41 %17 %
EBITDA-6.7b7.1b6.7b8.3b7.6b15.0b
% EBITDA margin-30 %32 %27 %31 %20 %34 %
Profit-3.0b2.2b1.3b3.2b112m5.5b
% profit margin-13 %10 %5 %12 %-12 %
EV / revenue-4.5x4.9x5.9x5.4x5.5x4.6x
EV / EBITDA-15.2x15.3x21.6x17.2x27.2x13.4x
R&D budget5.9b5.0b5.1b5.3b---
R&D % of revenue-22 %23 %22 %---

Source: Company fillings or news article

  • Edit

Recent News about AstraZeneca

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by AstraZeneca

Edit
Acerta Pharma
ACQUISITION by AstraZeneca Feb 2016
ZS Pharma
ACQUISITION by AstraZeneca Nov 2015
Alexion Pharmaceuticals
ACQUISITION by AstraZeneca Dec 2020
Almirall
ACQUISITION by AstraZeneca Jul 2014
Pearl Therapeutics
ACQUISITION by AstraZeneca Jun 2013
MedImmune
ACQUISITION by AstraZeneca Apr 2007
View 26 more